Tom Brady opens up.(Image via Getty Images)
In January 2026, the NFL legend backed a $200 million Series A funding round for the telehealth and digital healthcare startup,which helped push the Miami based company’s valuation above $2 billion. The NFL legend officially joined eMed as its founding Chief Wellness Officer in January 2026 and also holds a seat on the company’s board of directors.
In a press release, the New England Patriots’ icon Tom Brady said, “High-quality medical care should be accessible and delivered responsibly with decisions grounded in medical evidence and individual needs…” Tom Brady added, “At eMed, the focus is improving population health at scale by delivering best-in-class GLP-1 care to workforce populations. Tom Brady, the seven time Super Bowl champion, has always remained focused on his health and fitness even as he retired from the league. The NFL icon has been public about working out several times in the day to keep his mind and body refreshed. Amid the new season, tom Brady has marked a new achievement in one of his health tech platforms, eMed. These medications can be truly game-changing but only when paired with the right clinical guidance and ongoing support to protect long-term health. Ever since the seven time Super Bowl champion Tom Brady retired from the league, he has turned into a successful entrepreneur and a strategic investor as he has continued to invest in growing and upcoming brands to help them in different industries.
Linda Yaccarino, CEO of eMed, reflected on partnering with Tom Brady as she said, “GLP-1s are triggering a generational shift in healthcare and there’s no turning back…Their adoption is one of the most urgent challenges employers face today, and the need for smarter, more disciplined care around these medications has never been greater.